Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds get into 30-yr treasuries

Wednesday, May 30, 2012

Bailey McCann, Opalesque New York: Hedge funds are aggressively buying 30-yr T-bonds futures by ~500% to $7.2bn notional up from $1.2bn notional last week according to a new report from BofA Merrill Lynch Global Research. Funds are favoring longer duration treasuries opting to cover their shorts in 10-yrs and sell out of 2-yrs, according to Mary Ann Bartels, lead hedge fund analyst at BofA Merrill Lynch.

Long/Short hedge funds switched to growth and small cap tilt from neutral, while neutralizing quality preference. It’s the first time that Long/Short funds have favored small cap since February. They also sold NASDAQ 100 exposure to a slight net short. The investable hedge fund composite index was down 1.34% month-to-date (MTD) as of May 23, compared to down 5.65% for the S&P 500.

In terms of strategy performance, CTAs saw a slight recovery up +0.77%, CTAs are the only strategy with positive return MTD. Long/Short performed the worst, down -3.17%. Equity Long/Short bought market exposure to 35%, back to the 35-40% benchmark level, from 30% net long. Macros bought the S&P 500 and NASDAQ 100, partially covered their shorts in USD, held commodities steady, and sold the 10-year Treasuries to a net short for the first time since March.

......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its